Stay updated on Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated to version 2.14.1 on January 17, 2025, following the removal of version 2.14.0 on November 18, 2023.SummaryDifference1%
- Check73 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check102 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.